Home
About
Company
Organization
History
Team
Honor
Culture
Concept
Responsibility
Memoir
Video
News
Company notice
Company news
Media coverage
Innovation
Quality
HSE
Product
Halobios
Preparation
Raw material
Chinese Medicine
Health Products
Medical instrument
Service
Contact
Network
Stock code
603811
CN
Stock code
603811
Home
News
Company news
Chairman Zhang Dejiang inspected Chengyi Pharmaceutical
1999,03,03
0
Prev:
Qiao Chuanxiu, Deputy Secretary of Zhejiang Provincial Party Committee, inspected Chengyi Pharmaceutical
Next:
Xu Xingguan, Director of Zhejiang Provincial People's Congress, Inspects Chengyi Pharmaceutical
2024,04,27
Joint drugs have seen steady growth in revenue for many years, and fish oil health products have emerged as a rising star. Securities Times
2024,04,27
Realize a net profit of 163 million yuan in 2023 and adhere to a high proportion of dividends to give back to investors
2024,04,21
Cheng Yi Pharmaceutical insists on annual dividends to benefit all investors
2024,04,03
Cheng Yi Pharmaceutical Lidocaine Hydrochloride Injection Consistency Evaluation through Generic Drugs
Contact Us
view more
